AI	artificial intelligence
AKT	protein kinase B
AMD/nAMD	Age-Related Macular Degeneration/neovascular Age-Related Macular Degeneration
AMPK	AMP-activated protein kinase
Ang-2	angiopoietin-2
AQP4	aquaporin 4 channels
BA	bile acids
BCVA	best-corrected visual acuity
BRVO	branch retinal vein occlusion
BVOS	Branch Vein Occlusion Study
bFGF	basic fibroblast growth factor
CCL2	chemokine ligand 2
CD54	cluster of differentiation 54
CLP	conventional laser photocoagulation
CME	cystoid macular edema
CMT	central macular thickness
CRP	c-reactive protein
CRT	central retinal thickness
CRVO	central retinal vein occlusion
CVOS	Central Vein Occlusion Study
CXCL-10	C-X-C motif chemokine 10
DDD	defined daily doses
DEX	dexamethasone
DME	diabetic macular edema
DRIL	disorganisation of retinal inner layers
EC	endothelial cell
EMA	European Medicines Agency
ETDRS	Early Treatment Diabetic Retinopathy Study
EZ	ellipsoid zone
FA	fluorescein angiography
FAK	focal adhesion kinase
FAZ	foveal avascular zone
FDA	The United States Food and Drug Administration
FMT	fecal microbiota transplantation
GABA	gamma-aminobutyric acid
HF	hyperreflective foci
HIF-1	hypoxia-inducible factor-1
HRVO	hemi-retinal vein occlusion
IAI	intravitreal aflibercept
I-CRVO	ischemic central retinal vein occlusion
IDA	iron deficiency anemia
IGF-1	insulin-like growth factor 1
IL	interleukin
IOP	intraocular pressure
IP10	interferon gamma-induced protein 10
IRF	intraretinal fluid
ISI	ischemic index
LMWH	low molecular weight heparins
lncRNA	long non-coding RNAs
LPA-ATX	lysophosphatidic acid-autotaxin
LPS	lipopolysaccharides
MAPK	mitogen-activated protein kinase
MCP-1	monocyte chemoattractant protein 1
ME	macular edema
MMP	metalloproteinase
NLR	neutrophil-to-lymphocyte ratio
NI-CRVO	non-ischemic central retinal vein occlusion
NOAC	non-vitamin K-antagonist oral anticoagulant
NV	neovascularisation
NVG	neovascular glaucoma
OCT	optical coherence tomography
OCTA	optical coherence tomography angiography
OLM	outer limiting membrane
PAI-1	plasminogen activator inhibitor-1
PAMM	severe acute macular neuroretinopathy
PC	pericytes
PDGF-AA	platelet derived growth factor
PDS	Port Delivery System
PEDF	pigment epithelium-derived factor
PlGF	placental growth factor
PI3K	phosphatidylinositol 3-kinase
PLC-γ	phospholipase C gamma
PLR	platelet-to-lymphocyte ratio
PRP	panretinal photocoagulation
PVD	posterior vitreous detachment
QALY	quality-adjusted life year
RMG	Müller glial cells
RPE	retinal pigment epithelium
rtPA	systemic recombinant tissue plasminogen activator
RVO	retinal vein occlusion
SAA	serum amyloid A
SCFA	short-chain fatty acids
sICAM-1	soluble intercellular adhesion molecule 1
SMLP	sub-threshold micropulse laser photocoagulation
SRD	serous retinal detachment
SRF	subretinal fluid
SRT	selective retina therapy
SVD	small vessel disease
sVEGFR2	soluble vascular endothelial growth factor receptor 2
TGF-β	transforming growth factor β
TMAO	trimethylamine N-oxide
TNF	tumor necrosis factor
TRD	tractional retinal detachment
TUDCA	tauroursodeoxycholate
UWF-FA	ultra-widefield fluorescein angiography
VA	visual acuity
VALS	visual acuity letter score
VEGF	vascular endothelial growth factor
VH	vitreous hemorrhage
ZO-1	zonula occludens-1